Mr Elliot McClenaghan
Research Student - MPhil/PhD - Epidemiology & Population Health
United Kingdom
I am a doctoral candidate in Pharmacoepidemiology in the department of Medical Statistics and the Electronic Health Records group, where I investigate optimal causal inference and target trial emulation methodologies for treatment switching and deprescribing in cystic fibrosis. Previously I worked as a Research Fellow in the department of Infectious Disease Epidemiology and before that was a medical statistician at the UK Cystic Fibrosis Registry, where I designed and conducted post-authorisation drug safety studies and was lead statistician of a global registry collaboration on the impact of COVID-19 in people with cystic fibrosis. I studied Biomedical Sciences at Newcastle University and obtained an MPH in Public Health with a strong quantitative focus at Queen’s University Belfast.
Affiliations
Department of Medical Statistics
Faculty of Epidemiology and Population Health
Teaching
I have taught on various MSc modules and short courses at LSHTM including delivering lectures and co-organising on the Professional Certificate in Pharmacoepidemiology & Pharmacovigilance.
Research
My current doctoral research focuses on causal inference in pharmacoepidemiology and optimal statistical methods for target trial emulation using real-world data, applied to questions around treatment deprescribing and switching in cystic fibrosis. Previous work has focused on vaccine effectiveness, clinical data linkage and epidemiology of SARS-CoV-2 as part of the COVID-19 School Infection Survey collaboration. My previous research has also included drug safety, cystic fibrosis, global health and registry-based studies.
Research Area
Epidemiology
Applied statistics (medical)
Pharmacoepidemiology
Statistical methods
Disease and Health Conditions
Cystic fibrosis
COVID-19
Country
United Kingdom
Selected Publications
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
2022
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
2021
JOURNAL OF CYSTIC FIBROSIS
COVID-19 vaccine prioritisation for people with cystic fibrosis.
2021
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study
2021
Journal of Cystic Fibrosis
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
2020
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
What Predicts Hospital Admissions in Community-Dwelling People With Parkinsonism?
2019
Journal of geriatric psychiatry and neurology
Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry.
2018
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America